Canaloplasty Market by Surgical Technique, Application

List of Tables

[191 Pages Report] The Canaloplasty Market size was estimated at USD 517.26 million in 2023 and expected to reach USD 554.04 million in 2024, at a CAGR 7.26% to reach USD 845.15 million by 2030.

Canaloplasty is a medical procedure employed in treating glaucoma, a chronic condition of the eye due to increased intraocular pressure that can lead to optic nerve damage and, ultimately, loss of vision. Unlike more invasive surgical options, canaloplasty utilizes a microcatheter to enlarge the eye's natural drainage canal, facilitating a more manageable outflow of aqueous humor, the fluid responsible for maintaining eye pressure. This method presents a less aggressive alternative to traditional surgeries, aiming to reduce intraocular pressure while minimizing the risks associated with more invasive interventions. The canaloplasty market has witnessed significant growth, driven by the rising prevalence of glaucoma worldwide and the increasing need for less invasive surgical solutions. Aging populations, heightened awareness of glaucoma, and advancements in medical technology have further propelled the market forward. However, the market faces challenges, including the high cost of the procedure and the availability of alternative treatment options, including medication or other surgical procedures that may be more familiar to patients and practitioners. Furthermore, ongoing research and development aimed at enhancing the efficacy and safety of the method, coupled with growing healthcare infrastructure and increasing patient selection for minimally invasive surgeries, are expected to offer fertile ground for market expansion. Moreover, efforts to enhance the affordability and accessibility of canaloplasty can potentially increase its adoption, presenting a promising outlook for stakeholders in the glaucoma treatment landscape.

KEY MARKET STATISTICS
Base Year [2023]	USD 517.26 million
Estimated Year [2024]	USD 554.04 million
Forecast Year [2030]	USD 845.15 million
CAGR (%)	7.26%

Surgical Technique: Growing preference for the ab-interno canaloplasty technique for its minimally invasive nature

Ab-externo canaloplasty is where the surgeon creates a small incision in the eye tissue to access the schlemm's canal, a crucial component of the eye's drainage system. Once accessed, a microcatheter is inserted into the canal to enlarge and facilitate better fluid drainage. The surgeon may also inject a gel-like material to keep the canal open. This method is notable for significantly reducing intraocular pressure without requiring a complete removal of eye tissue, offering a less invasive option than traditional glaucoma surgeries. The ab-interno canaloplasty technique, in contrast, is performed from inside the eye. It is a newer approach involving a microscopic incision through the cornea to directly access the schlemm's canal. Similar to the ab-externo method, a microcatheter or a specialized device is used to dilate the canal and facilitate fluid drainage, whereas it is done without creating an external incision. This procedure is often preferred for its minimally invasive nature, reduced recovery times, and because it can be performed with other minimally invasive glaucoma surgeries (MIGS) to achieve better pressure control.

Application: Emerging applications of canaloplasty in hospitals and ophthalmology clinics

In academic and research laboratories, canaloplasty is a subject of study rather than a treatment applied directly to patients. These settings prioritize investigating the efficacy, safety, and potential improvements of canaloplasty as a treatment for glaucoma. Research labs and academic institutions often conduct clinical trials, analyze outcomes, and compare canaloplasty to other glaucoma treatments. These environments aim to advance understanding, refine techniques, and contribute to the knowledge surrounding this minimally invasive procedure. Ambulatory surgical centers (ASCs) offer a setting where patients can undergo this procedure without needing hospital admission. Using ASCs for canaloplasty underscores the procedure's minimally invasive nature, emphasizing patient convenience, reduced costs, and efficiency. Hospitals and ophthalmology clinics serve as primary points of care for patients undergoing canaloplasty. These institutions have the necessary infrastructure and specialized personnel to perform this delicate eye surgery. Ophthalmology clinics, often part of or affiliated with larger hospital systems, provide focused expertise in eye health, including access to ophthalmologists skilled in canaloplasty.

Regional Insights

In the Americas, the need for canaloplasty procedures is chiefly driven by an aging population vulnerable to glaucoma and an established healthcare infrastructure that facilitates access to advanced ophthalmic treatments. The region benefits from a proactive regulatory environment, with agencies, including the U.S. Food and Drug Administration (FDA), setting stringent guidelines that ensure the safety and efficacy of canaloplasty devices and procedures. In the Asia-Pacific (APAC) region, rapid economic growth, improved healthcare standards, and increased healthcare spending have catalyzed the adoption of advanced medical treatments, including canaloplasty. The region's vast patient pool and growing awareness about glaucoma management options contribute to the procedure's growing need. The EMEA region presents a diverse landscape for canaloplasty, with increasing technology adoption underpinned by strong regulatory bodies inlcuding the European Medicines Agency (EMA). These agencies ensure that canaloplasty devices meet high safety and performance standards. In contrast, the Middle East and Africa are gradually growing, driven by increasing investments in healthcare infrastructure and a growing recognition of the need for advanced glaucoma management solutions. Despite the diversity, the overarching trend in EMEA is towards embracing minimally invasive procedures like canaloplasty, facilitated by evolving regulatory standards and an increasing emphasis on patient-centered care.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Canaloplasty Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Canaloplasty Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Canaloplasty Market, highlighting leading vendors and their innovative profiles. These include Carl Zeiss Meditec AG, Ellex Medical Pty Ltd., Glaukos Corporation, iSTAR Medical, Nova Eye Medical Limited, Qura, Inc., and Sight Sciences, Inc..

Market Segmentation & Coverage

This research report categorizes the Canaloplasty Market to forecast the revenues and analyze trends in each of the following sub-markets:

Surgical Technique
- Ab-Externo Canaloplasty
- Ab-Interno Canaloplasty

Application
- Academy & Research Laboratory
- Ambulatory Surgical Centers
- Hospitals & Ophthalmology Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Canaloplasty Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Canaloplasty Market?

3. What are the technology trends and regulatory frameworks in the Canaloplasty Market?

4. What is the market share of the leading vendors in the Canaloplasty Market?

5. Which modes and strategic moves are suitable for entering the Canaloplasty Market?

Product Code: MRR-8958E923A70E

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing geriatric population, along with the increasing prevalence of glaucoma worldwide
  - 5.1.1.2. Government initiatives regarding glaucoma awareness
  - 5.1.1.3. Growing healthcare infrastructure and preference for minimally invasive surgeries
- 5.1.2. Restraints
  - 5.1.2.1. High cost of canaloplasty devices and variability in insurance coverage
- 5.1.3. Opportunities
  - 5.1.3.1. Investment in R&D for developing more advanced, user-friendly canaloplasty devices
  - 5.1.3.2. Emerging partnerships between medical device manufacturers, pharmaceutical companies, and healthcare institutions
- 5.1.4. Challenges
  - 5.1.4.1. Limited efficacy of canaloplasty for advanced glaucoma with risk of complications
5.2. Market Segmentation Analysis
- 5.2.1. Surgical Technique: Growing preference for the ab-interno canaloplasty technique for its minimally invasive nature
- 5.2.2. Application: Emerging applications of canaloplasty in hospitals and ophthalmology clinics
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Canaloplasty Market, by Surgical Technique

6.1. Introduction
6.2. Ab-Externo Canaloplasty
6.3. Ab-Interno Canaloplasty

7. Canaloplasty Market, by Application

7.1. Introduction
7.2. Academy & Research Laboratory
7.3. Ambulatory Surgical Centers
7.4. Hospitals & Ophthalmology Clinics

8. Americas Canaloplasty Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Canaloplasty Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Canaloplasty Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
- 11.3.1. FDA Approves Nova Eye Medical's Advancement in Minimally Invasive Eye Surgery
- 11.3.2. Sight Sciences Launches the Ergo Series OmniR for Enhanced Canaloplasty Procedures
- 11.3.3. Unlocking New Frontiers in Glaucoma Treatment with the Research Alliance Between Verana Health and Sight Sciences
11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

12.1. Key Company Profiles
12.2. Key Product Portfolio